Your browser doesn't support javascript.
loading
Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D.
Kennedy, Susan A; Jarboui, Mohamed-Ali; Srihari, Sriganesh; Raso, Cinzia; Bryan, Kenneth; Dernayka, Layal; Charitou, Theodosia; Bernal-Llinares, Manuel; Herrera-Montavez, Carlos; Krstic, Aleksandar; Matallanas, David; Kotlyar, Max; Jurisica, Igor; Curak, Jasna; Wong, Victoria; Stagljar, Igor; LeBihan, Thierry; Imrie, Lisa; Pillai, Priyanka; Lynn, Miriam A; Fasterius, Erik; Al-Khalili Szigyarto, Cristina; Breen, James; Kiel, Christina; Serrano, Luis; Rauch, Nora; Rukhlenko, Oleksii; Kholodenko, Boris N; Iglesias-Martinez, Luis F; Ryan, Colm J; Pilkington, Ruth; Cammareri, Patrizia; Sansom, Owen; Shave, Steven; Auer, Manfred; Horn, Nicola; Klose, Franziska; Ueffing, Marius; Boldt, Karsten; Lynn, David J; Kolch, Walter.
Afiliação
  • Kennedy SA; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Jarboui MA; Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
  • Srihari S; Werner Siemens Imaging Center, University of Tübingen, Tübingen, Germany.
  • Raso C; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Bryan K; QIMR-Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
  • Dernayka L; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Charitou T; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Bernal-Llinares M; Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
  • Herrera-Montavez C; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Krstic A; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Matallanas D; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Kotlyar M; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Jurisica I; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Curak J; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Wong V; Krembil Research Institute, University Health Network, Toronto, Canada.
  • Stagljar I; Krembil Research Institute, University Health Network, Toronto, Canada.
  • LeBihan T; Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, Canada.
  • Imrie L; Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Pillai P; Donnelly Centre, University of Toronto, Toronto, Canada.
  • Lynn MA; Department of Biochemistry, University of Toronto, Toronto, Canada.
  • Fasterius E; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Al-Khalili Szigyarto C; Donnelly Centre, University of Toronto, Toronto, Canada.
  • Breen J; Department of Biochemistry, University of Toronto, Toronto, Canada.
  • Kiel C; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Serrano L; Donnelly Centre, University of Toronto, Toronto, Canada.
  • Rauch N; Department of Biochemistry, University of Toronto, Toronto, Canada.
  • Rukhlenko O; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Kholodenko BN; Mediterranean Institute for Life Sciences, Split, Croatia.
  • Iglesias-Martinez LF; Synthetic and Systems Biology, University of Edinburgh, Edinburgh, UK.
  • Ryan CJ; Synthetic and Systems Biology, University of Edinburgh, Edinburgh, UK.
  • Pilkington R; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Cammareri P; EMBL Australia Group, South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Sansom O; School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Shave S; School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Auer M; Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Horn N; School of Biological Sciences, University of Adelaide Bioinformatics Hub, Adelaide, SA, Australia.
  • Klose F; Computational & Systems Biology Program, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Ueffing M; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
  • Boldt K; Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Lynn DJ; Conway Institute, University College Dublin, Dublin, Ireland.
  • Kolch W; Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Nat Commun ; 11(1): 499, 2020 01 24.
Article em En | MEDLINE | ID: mdl-31980649
ABSTRACT
Protein-protein-interaction networks (PPINs) organize fundamental biological processes, but how oncogenic mutations impact these interactions and their functions at a network-level scale is poorly understood. Here, we analyze how a common oncogenic KRAS mutation (KRASG13D) affects PPIN structure and function of the Epidermal Growth Factor Receptor (EGFR) network in colorectal cancer (CRC) cells. Mapping >6000 PPIs shows that this network is extensively rewired in cells expressing transforming levels of KRASG13D (mtKRAS). The factors driving PPIN rewiring are multifactorial including changes in protein expression and phosphorylation. Mathematical modelling also suggests that the binding dynamics of low and high affinity KRAS interactors contribute to rewiring. PPIN rewiring substantially alters the composition of protein complexes, signal flow, transcriptional regulation, and cellular phenotype. These changes are validated by targeted and global experimental analysis. Importantly, genetic alterations in the most extensively rewired PPIN nodes occur frequently in CRC and are prognostic of poor patient outcomes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Transformação Celular Neoplásica / Proteínas Proto-Oncogênicas p21(ras) / Mapas de Interação de Proteínas / Receptores ErbB / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Transformação Celular Neoplásica / Proteínas Proto-Oncogênicas p21(ras) / Mapas de Interação de Proteínas / Receptores ErbB / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irlanda